Clin2
NCT07403552Likely a fitRecruiting

Testing a new drug's safety in healthy volunteers

Healthy

This trial is testing a new drug called NSHO-101 in healthy people to see how the body processes it and if it is safe. It helps researchers learn about the drug before testing it in patients with a condition.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be at least 18 years old.
  • You must be in good health, as confirmed by a medical checkup.
  • You must be able to take pills or capsules without difficulty.
  • You must not have any serious medical conditions or allergies to the drug ingredients.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06845839Recruiting· Phase 1
Testing a new drug in healthy volunteers

This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.

Fair Lawn, New Jersey
NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai
NCT07126704Not yet recruiting· Phase 1
Testing the safety of a new oral drug in healthy men

This trial tests a new oral medication, called FB-101, in healthy adult men to see how safe it is and how the body processes it. Participation involves multiple visits and taking the drug in different doses.

Seoul
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT07219368Recruiting· Phase 1
Testing a new drug (MT-201) safety in healthy adults

This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.

San Diego, California
NCT07143331Not yet recruiting· Phase 1
Testing a new medicine for safety in healthy volunteers

This study tests a new medicine called KS101 to see if it is safe and how it works in healthy people for the first time. It is a first-in-human trial, meaning this is the first time the drug is given to people, and your health will be closely monitored throughout.

Sydney, New South Wales

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.